Literature DB >> 3709632

The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.

U F Legler, L Z Benet.   

Abstract

The protein binding of prednisolone was studied in plasma obtained from healthy volunteers in the presence of added amounts of prednisone and hydrocortisone. The plasma protein binding was determined using in vitro equilibrium dialysis for 16 h at 37 degrees C against isotonic Krebs-Ringer buffer using radioactive prednisolone. Prednisone appeared to have no effect on prednisolone binding. This surprising result was observed even when prednisone concentrations were more than 35 fold greater than prednisolone concentrations. In contrast, a marked competition between hydrocortisone and prednisolone was observed. These binding data were fit using a nonlinear least squares regression computer program and the capacity and affinity constants for the binding of prednisolone to transcortin and albumin were estimated including the competition for binding sites between prednisolone and hydrocortisone. The results from these studies compare favorably with recent parameter calculations, and our previous work where differences in binding were noted between cushingoid and noncushingoid patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709632     DOI: 10.1007/bf00614195

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Ultrafiltration studies of steroid-protein binding.

Authors:  P S CHEN; I H MILLS; F C BARTTER
Journal:  J Endocrinol       Date:  1961-10       Impact factor: 4.286

2.  Prednisone side-effects and serum-protein levels. A collaborative study.

Authors:  G P Lewis; W J Jusko; L Graves; C W Burke
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

3.  The simultaneous estimation of plasma cortisol and transcortin binding characteristics by a competitive protein binding technique.

Authors:  P J Pegg; P M Keane
Journal:  Steroids       Date:  1969-12       Impact factor: 2.668

4.  Plasma protein binding of prednisolone in normal volunteers and arthritic patients.

Authors:  I T Ağabeyoğlu; R F Bergstrom; W R Gillespie; J G Wagner; D R Kay
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

5.  Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.

Authors:  T N Tozer; J G Gambertoglio; D E Furst; D S Avery; N H Holford
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

6.  Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients.

Authors:  F J Frey; W J Amend; F Lozada; B M Frey; N H Holford; L Z Benet
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.

Authors:  F J Frey; B M Frey; L Z Benet
Journal:  Clin Chem       Date:  1979-11       Impact factor: 8.327

8.  Prednisolone disposition in steroid-dependent asthmatics.

Authors:  J Q Rose; J A Nickelsen; E Middleton; A M Yurchak; B H Park; W J Jusko
Journal:  J Allergy Clin Immunol       Date:  1980-11       Impact factor: 10.793

9.  Prednisolone clearance at steady state in man.

Authors:  U F Legler; F J Frey; L Z Benet
Journal:  J Clin Endocrinol Metab       Date:  1982-10       Impact factor: 5.958

10.  Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone.

Authors:  F J Frey; W J Amend; F Lozada; B M Frey; L Z Benet
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

View more
  5 in total

Review 1.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

Authors:  C Rollin; O Chosidow; B Diquet; C Dutreuil; S Herson; J Revuz; J C Delchier
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.

Authors:  L E Gustavson; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

5.  A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma.

Authors:  J Xu; J Winkler; H Derendorf
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-02-23       Impact factor: 2.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.